Kyoto, Japan

Kaori Hanaoka

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kaori Hanaoka. Retrieved from https://idiyas.com/inventor/kaori-hanaoka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaori Hanaoka: Innovator in Anemia Treatment

Introduction

Kaori Hanaoka is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anemia. Her innovative work has led to the development of new compounds that hold promise for improving patient outcomes.

Latest Patents

Hanaoka holds a patent for "Pyrazolopyridine compounds for the treatment of anemia." This patent represents her commitment to addressing critical health issues and showcases her expertise in medicinal chemistry. She has successfully developed a solution that could potentially benefit many individuals suffering from this condition.

Career Highlights

Hanaoka is currently employed at Fujisawa Pharmaceutical Company, Ltd., where she continues to advance her research and development efforts. Her work at this esteemed organization has allowed her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Yutaka Kohno and Itsuo Nagatomi. Together, they contribute to a dynamic team focused on innovative solutions in healthcare.

Conclusion

Kaori Hanaoka's contributions to the field of anemia treatment through her patented innovations highlight her role as a leading inventor in the pharmaceutical industry. Her work not only reflects her dedication to improving health outcomes but also underscores the importance of collaboration in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…